心脏重编程相关机制研究进展
Research Progress of Cardiac Reprogramming Mechanism
DOI: 10.12677/ACM.2022.126742, PDF,    科研立项经费支持
作者: 李 萌, 宋延彬*：延安大学附属医院心血管病内科，陕西 延安
关键词: 心肌细胞；直接重编程；成纤维细胞；再生；重编程机制；Myocardial Cells； Direct Reprogramming； Fibroblasts； Regeneration； Reprogramming Mechanism
摘要: 心肌梗死占心血管疾病死亡率的50%。由于梗死部位发生纤维化重塑，在急性心肌梗死中幸存下来的人有着心力衰竭的显著风险。传统治疗方法可改善心脏血供，无法使已经受损的心肌细胞再生，而心脏再生医学的兴起为心肌梗死的治疗提供了新出路。心脏重编程可增加功能性心肌细胞数量并且减少心肌梗死后纤维化面积。本文主要介绍心脏直接重编程方法和相关机制研究，尤其是关于心脏重编程相关机制的研究进展。
Abstract: Myocardial infarction accounts for 50% of the mortality of cardiovascular diseases. People who sur-vive an acute myocardial infarction are at significant risk of heart failure due to fibrotic remodeling at the infarct site. Traditional treatment methods can improve the blood supply to the heart, but cannot regenerate damaged myocardial cells. However, the rise of cardiac regenerative medicine provides a new way for the treatment of myocardial infarction. Cardiac reprogramming increases the number of functional cardiomyocytes and reduces the area of fibrosis after myocardial infarc-tion. This paper mainly introduces the methods and mechanisms of cardiac direct reprogramming, especially the research progress on the mechanisms of cardiac reprogramming.
文章引用：李萌, 宋延彬. 心脏重编程相关机制研究进展[J]. 临床医学进展, 2022, 12(6): 5121-5127. https://doi.org/10.12677/ACM.2022.126742

参考文献

[1] Ieda, M., Fu, J.D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B.G. and Srivastava, D. (2010) Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors. Cell, 142, 375-386. [Google Scholar] [CrossRef] [PubMed]
[2] Song, K., Nam, Y.J., Luo, X., Qi, X., Tan, W., Huang, G.N., Acharya, A., Smith, C.L., Tallquist, M.D., Neilson, E.G., Hill, J.A., Bassel-Duby, R. and Olson, E.N. (2012) Heart Re-pair by Reprogramming Non-Myocytes with Cardiac Transcription Factors. Nature, 485, 599-604. [Google Scholar] [CrossRef] [PubMed]
[3] Addis, R.C., Ifkovits, J.L., Pinto, F., Kellam, L.D., Esteso, P., Rentschler, S., Christoforou, N., Epstein, J.A. and Gearhart, J.D. (2013) Optimization of Direct Fibroblast Reprogramming to Car-diomyocytes Using Calcium Activity as a Functional Measure of Success. Journal of Molecular and Cellular Cardiology, 60, 97-106. [Google Scholar] [CrossRef] [PubMed]
[4] Christoforou, N., Chellappan, M., Adler, A.F., Kirkton, R.D., Wu, T., Addis, R.C., Bursac, N. and Leong, K.W. (2013) Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 En-hance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming. PLoS One, 8, e63577. [Google Scholar] [CrossRef] [PubMed]
[5] Zhao, H., Zhang, Y., Xu, X., Sun, Q., Yang, C., Wang, H., Yang, J., Yang, Y., Yang, X., Liu, Y. and Zhao, Y. (2021) Sall4 and Myocd Empower Direct Cardiac Reprogramming from Adult Cardiac Fibroblasts after Injury. Frontiers in Cell and Developmental Biology, 9, 608367. [Google Scholar] [CrossRef] [PubMed]
[6] Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E. and Melton, D.A. (2008) Induction of Pluripotent Stem Cells by Defined Factors Is Greatly Improved by Small-Molecule Compounds. Nature Biotechnology, 26, 795-797. [Google Scholar] [CrossRef] [PubMed]
[7] Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y. and Deng, H. (2013) Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds. Science, 341, 651-654. [Google Scholar] [CrossRef] [PubMed]
[8] Fu, Y., Huang, C., Xu, X., Gu, H., Ye, Y., Jiang, C., Qiu, Z. and Xie, X. (2015) Direct Reprogramming of Mouse Fibroblasts into Cardiomyocytes with Chemical Cocktails. Cell Research, 25, 1013-1024. [Google Scholar] [CrossRef] [PubMed]
[9] Jayawardena, T.M., Egemnazarov, B., Finch, E.A., Zhang, L., Payne, J.A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M. and Dzau, V.J. (2012) MicroRNA-Mediated in Vitro and in Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes. Circulation Research, 110, 1465-1473. [Google Scholar] [CrossRef] 
[10] Muraoka, N., Yamakawa, H., Miyamoto, K., Sadahiro, T., Umei, T., Isomi, M., Nakashima, H., Akiyama, M., Wada, R., Inagawa, K., Nishiyama, T., Kaneda, R., Fukuda, T., Takeda, S., Tohyama, S., Hashimoto, H., Kawamura, Y., Goshima, N., Aeba, R., Yamagishi, H., Fukuda, K. and Ieda, M. (2014) MiR-133 Promotes Cardiac Reprogramming by Directly Repressing Snai1 and Silencing Fibroblast Signa-tures. The EMBO Journal, 33, 1565-1581. [Google Scholar] [CrossRef] [PubMed]
[11] Huang, S., Li, X., Zheng, H., Si, X., Li, B., Wei, G., Li, C., Chen, Y., Chen, Y., Liao, W., Liao, Y. and Bin, J. (2019) Loss of Super-Enhancer-Regulated circRNANfix Induces Cardiac Regeneration after Myocardial Infarction in Adult Mice. Circulation, 139, 2857-2876. [Google Scholar] [CrossRef] 
[12] Ifkovits, J.L., Addis, R.C., Epstein, J.A. and Gearhart, J.D. (2014) Inhibition of TGFβ Signaling Increases Direct Conversion of Fibroblasts to Induced Cardiomyo-cytes. PLoS One, 9, e89678. [Google Scholar] [CrossRef] [PubMed]
[13] Zhao, Y., Londono, P., Cao, Y., Sharpe, E.J., Proenza, C., O’Rourke, R., Jones, K.L., Jeong, M.Y., Walker, L.A., Buttrick, P.M., McKinsey, T.A. and Song, K. (2015) High-Efficiency Reprogramming of Fibroblasts into Cardiomyocytes Requires Suppression of Pro-Fibrotic Signalling. Nature Communications, 6, Article No. 8243. [Google Scholar] [CrossRef] [PubMed]
[14] Abad, M., Hashimoto, H., Zhou, H., Morales, M.G., Chen, B., Bas-sel-Duby, R. and Olson, E.N. (2017) Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Tran-scriptional Activity. Stem Cell Reports, 8, 548-560. [Google Scholar] [CrossRef] [PubMed]
[15] Hashimoto, H., Wang, Z., Garry, G.A., Malladi, V.S., Botten, G.A., Ye, W., Zhou, H., Osterwalder, M., Dickel, D.E., Visel, A., Liu, N., Bassel-Duby, R. and Olson, E.N. (2019) Cardiac Reprogramming Factors Synergistically Activate Genome-Wide Cardiogenic Stage-Specific Enhancers. Cell Stem Cell, 25, 69-86.e5. [Google Scholar] [CrossRef] [PubMed]
[16] Lee, J., Sayed, N., Hunter, A., Au, K.F., Wong, W.H., Mocarski, E.S., Pera, R.R., Yakubov, E. and Cooke, J.P. (2012) Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming. Cell, 151, 547-558. [Google Scholar] [CrossRef] [PubMed]
[17] Sayed, N., Ospino, F., Himmati, F., Lee, J., Chanda, P., Mocarski, E.S. and Cooke, J.P. (2017) Retinoic Acid Inducible Gene 1 Protein (RIG1)-Like Receptor Pathway Is Required for Ef-ficient Nuclear Reprogramming. Stem Cells, 35, 1197-1207. [Google Scholar] [CrossRef] [PubMed]
[18] Hu, J., Hodg-kinson, C.P., Pratt, R.E., Lee, J., Sullenger, B.A. and Dzau, V.J. (2020) Enhancing Cardiac Reprogramming via Synthet-ic RNA Oligonucleotides. Molecular Therapy Nucleic Acids, 23, 55-62. [Google Scholar] [CrossRef] [PubMed]
[19] Zhou, Y., Liu, Z., Welch, J.D., Gao, X., Wang, L., Garbutt, T., Keepers, B., Ma, H., Prins, J.F., Shen, W., Liu, J. and Qian, L. (2019) Single-Cell Transcriptomic Analyses of Cell Fate Transitions during Human Cardiac Reprogramming. Cell Stem Cell, 25, 149-164.e9. [Google Scholar] [CrossRef] [PubMed]
[20] Muraoka, N., Nara, K., Tamura, F., Kojima, H., Yamakawa, H., Sadahiro, T., Miyamoto, K., Isomi, M., Haginiwa, S., Tani, H., Kurotsu, S., Osakabe, R., Torii, S., Shimizu, S., Okano, H., Sugimoto, Y., Fukuda, K. and Ieda, M. (2019) Role of Cyclooxygenase-2-Mediated Prostaglandin E2-Prostaglandin E Receptor 4 Signaling in Cardiac Reprogramming. Nature Communications, 10, Article No. 674. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, S., Xia, P., Ye, B., Huang, G., Liu, J. and Fan, Z. (2013) Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogram-ming to Pluripotency. Cell Stem Cell, 13, 617-625. [Google Scholar] [CrossRef] [PubMed]
[22] Ma, T., Li, J., Xu, Y., Yu, C., Xu, T., Wang, H., Liu, K., Cao, N., Nie, B.M., Zhu, S.Y., Xu, S., Li, K., Wei, W.G., Wu, Y., Guan, K.L. and Ding, S. (2015) Atg5-Independent Autophagy Regulates Mitochondrial Clearance and Is Essential for iPSC Reprogramming. Nature Cell Biology, 17, 1379-1387. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, L., Ma, H., Huang, P., Xie, Y., Near, D., Wang, H., Xu, J., Yang, Y., Xu, Y., Garbutt, T., Zhou, Y., Liu, Z., Yin, C., Bressan, M., Taylor, J.M., Liu, J. and Qian, L. (2020) Down-regulation of Beclin1 Promotes Direct Cardiac Reprogramming. Science Translational Medicine, 12, eaay7856. [Google Scholar] [CrossRef] [PubMed]
[24] Dal-Pra, S., Hodgkinson, C.P., Mirotsou, M., Kirste, I. and Dzau, V.J. (2017) Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo. Circulation Research, 120, 1403-1413. [Google Scholar] [CrossRef] 
[25] Zhou, Y., Wang, L., Vaseghi, H.R., Liu, Z., Lu, R., Ali-mohamadi, S., Yin, C., Fu, J.D., Wang, G.G., Liu, J. and Qian, L. (2016) Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. Cell Stem Cell, 18, 382-395. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, L., Lei, I., Karatas, H., Li, Y., Wang, L., Gnatovskiy, L., Dou, Y., Wang, S., Qian, L. and Wang, Z. (2016) Targeting Mll1 H3K4 Methyltransferase Activity to Guide Cardiac Lineage Specific Reprogramming of Fibroblasts. Cell Discovery, 2, Article No. 16036. [Google Scholar] [CrossRef] [PubMed]
[27] Schiebinger, G., Shu, J., Tabaka, M., Cleary, B., Subramanian, V., Solomon, A., Gould, J., Liu, S., Lin, S., Berube, P., Lee, L., Chen, J., Brumbaugh, J., Rigollet, P., Hochedlinger, K., Jaenisch, R., Regev, A. and Lander, E.S. (2019) Optimal-Transport Analysis of Single-Cell Gene Expression Identifies Developmental Trajectories in Reprogramming. Cell, 176, 928-943.e22. [Google Scholar] [CrossRef] [PubMed]
[28] Xing, Q.R., El Farran, C.A., Gautam, P., Chuah, Y.S., Warrier, T., Toh, C.X.D., Kang, N.Y., Sugii, S., Chang, Y.T., Xu, J., Collins, J.J., Daley, G.Q., Li, H., Zhang, L.F. and Loh, Y.H. (2020) Diversification of Reprogramming Trajectories Revealed by Parallel Single-Cell Transcriptome and Chromatin Accessibility Sequencing. Science Advances, 6, eaba1190. [Google Scholar] [CrossRef] [PubMed]
[29] Cao, J., Cusanovich, D.A., Ramani, V., Aghamirzaie, D., Pliner, H.A., Hill, A.J., Daza, R.M., McFaline-Figueroa, J.L., Packer, J.S., Christiansen, L., Steemers, F.J., Adey, A.C., Trapnell, C. and Shendure, J. (2018) Joint Profiling of Chromatin Ac-cessibility and Gene Expression in Thousands of Single Cells. Science, 361, 1380-1385. [Google Scholar] [CrossRef] [PubMed]
[30] Deng, Y., Bao, F., Dai, Q., Wu, L.F. and Altschuler, S.J. (2019) Scalable Analysis of Cell-Type Composition from Single-Cell Transcriptomics Using Deep Recurrent Learning. Nature Methods, 16, 311-314. [Google Scholar] [CrossRef] [PubMed]
[31] Wang, H., Yang, Y., Qian, Y., Liu, J. and Qian, L. (2021) Delin-eating Chromatin Accessibility Re-Patterning at Single Cell Level during Early Stage of Direct Cardiac Reprogramming. Journal of Molecular and Cellular Cardiology, 162, 62-71. [Google Scholar] [CrossRef] [PubMed]
[32] Kurotsu, S., Sadahiro, T., Fujita, R., Tani, H., Yamakawa, H., Tamura, F., Isomi, M., Kojima, H., Yamada, Y., Abe, Y., Murakata, Y., Akiyama, T., Muraoka, N., Harada, I., Suzuki, T., Fukuda, K. and Ieda, M. (2020) Soft Matrix Promotes Cardiac Reprogramming via Inhibition of YAP/TAZ and Sup-pression of Fibroblast Signatures. Stem Cell Reports, 15, 612-628. [Google Scholar] [CrossRef] [PubMed]
[33] Yamakawa, H., Muraoka, N., Miyamoto, K., Sadahiro, T., Isomi, M., Haginiwa, S., Kojima, H., Umei, T., Akiyama, M., Kuishi, Y., Kurokawa, J., Furukawa, T., Fukuda, K. and Ieda, M. (2015) Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under De-finedConditions. Stem Cell Reports, 5, 1128-1142. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, Y., Shi, S., Liu, H. and Meng, L. (2016) Hypoxia Enhances Direct Reprogramming of Mouse Fibroblasts to Cardiomyo-cyte-Like Cells. Cell Reprogramming, 18, 1-7. [Google Scholar] [CrossRef] [PubMed]

为你推荐